Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterobifunctional inhibitors of E-selectin and galectin-3

Heterobifunctional inhibitors of E-selectin and galectin-3

US Patent 11548908 · Granted Jan 10, 2023

Estimated economic value: $3,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bridged tricyclic carbamoylpyridone compounds and uses thereof2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use2025
MCL1 inhibitors2025
Substituted pyridotriazine compounds and uses thereof2025
MCL-1 inhibitors2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof2024
E-selectin antagonist compounds, compositions, and methods of use2024
E-selectin antagonist compounds, compositions, and methods of use2024
Substituted pyridotriazine compounds and uses thereof2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024